Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 177

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation

Open access
Roos-Weil, Damien, Dietrich, Sascha, Boumendil, Ariane, Polge, Emmanuelle, Bron, Dominique, Carreras, Enric, Iriondo Atienza, Arturo, Arcese, William, Beelen, Dietrich W., Cornelissen, Jan J., Kröger, Nicolaus, Milone, Giuseppe, Rossi, Giuseppe, Jardin, Fabrice, Peters, Christina, Rocha, Vanderson, Sureda, Anna, Mohty, Mohamad, Dreger, Peter·2013·Blood

Abstract

Patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) have a poor prognosis with conventional chemotherapy. In the present study, we retrospectively analyzed the outcome of patients with BPDCN who underwent allogeneic stem cell transplantation (allo-SCT) or autologous stem cell transplantation (auto-SCT). A total of 39 patients (allo-SCT, n = 34; auto-SCT, n = 5) were identified in the European Group for Blood and Marrow Transplantation registry. The 34 allo-SCT patients had a median age of 41 years (range, 10-70) and received transplantations from sibling (n = 11) or unrelated donors (n = 23) between 2003 and 2009. MAC was used in 74% of patients. Nineteen allo-SCT patients (56%) received transplantations in first complete remission. The 3-year cumulative incidence of relapse, disease-free survival, and overall survival was 32%, 33%, and 41%, respectively. By univariate comparison, being in first remission at allo-SCT favorably influenced survival, whereas age, donor source, and chronic GVHD had no significant impact. We conclude that high-dose therapy followed by allo-SCT from related or unrelated donors can provide durable remission even in elderly patients with BPDCN. However, it remains to be shown if graft-versus-malignancy effects can contribute significantly to BPDCN control after allo-SCT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2012-08-448613

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 177

Metadata

Authors
Roos-Weil, D., Dietrich, S., Boumendil, A., Polge, E., Bron, D., Carreras, E., Iriondo Atienza, A., Arcese, W., Beelen, D. W., Cornelissen, J. J., Kröger, N., Milone, G., Rossi, G., Jardin, F., Peters, C., Rocha, V., Sureda, A., Mohty, M., & Dreger, P.
Venue
Blood
Published
2013-01-17
Volume
121
Issue
3
Pages
440-446
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W1998650989
Cited by
177
References
1
FWCI
6.15
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation. https://app.cochat.ai/papers/10.1182/blood-2012-08-448613
The paper
Roos-Weil, D., Dietrich, S., Boumendil, A., Polge, E., Bron, D., Carreras, E., Iriondo Atienza, A., Arcese, W., Beelen, D. W., Cornelissen, J. J., Kröger, N., Milone, G., Rossi, G., Jardin, F., Peters, C., Rocha, V., Sureda, A., Mohty, M., & Dreger, P. (2013). Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation. Blood. https://doi.org/10.1182/blood-2012-08-448613

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.